Informazioni su CareDx, Inc. - Common Stock Panoramica della società da Wikipedia

Wikidata ↗

CDNA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo

$46.23

Capitalizzazione di Mercato

$2.37B

P/E (TTM)

-116.4

EPS (TTM)

$-0.40

Ricavi (TTM)

$380M

Rendimento div.

—

ROE

-6.8%

D/E Debito/Patrimonio

—

Intervallo 52 sett.

$11 – $50

CDNA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $380M

2017-12-31 → 2025-12-31

EPS $-0.40

2017-12-31 → 2025-12-31

Flusso di cassa libero —

2017-12-31 → 2018-12-31

Margini -5.6%

2019-12-31 → 2019-12-31

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica

Tendenza 5 anni

CDNA

Mediana dei peer

P/E (TTM)

-116.4

55.4

P/S (TTM)

6.2

7.7

P/B

7.8

7.1

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica

Tendenza 5 anni

CDNA

Mediana dei peer

Operating Margin (Margine Operativo)

-8.1%

—

Net Profit Margin (Margine di Profitto Netto)

-5.6%

-2.0%

ROA

-4.7%

-32.7%

ROE

-6.8%

-37.9%

ROIC

-10.3%

—

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica

Tendenza 5 anni

CDNA

Mediana dei peer

Current Ratio (Rapporto corrente)

2.9

7.4

Quick Ratio

2.4

—

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica

Tendenza 5 anni

CDNA

Mediana dei peer

Revenue YoY (Ricavi YoY)

13.8%

—

Revenue CAGR 3Y (CAGR Ricavi 3Y)

5.7%

—

Revenue CAGR 5Y (CAGR Ricavi 5Y)

14.6%

—

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica

Tendenza 5 anni

CDNA

Mediana dei peer

EPS (Diluted) (EPS (Diluito))

$-0.40

—

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica

Tendenza 5 anni

CDNA

Mediana dei peer

CDNA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 13 analisti

Acquisto forte 5 38,5%
Compra 3 23,1%
Mantieni 5 38,5%
Vendi 0 0,0%
Vendita forte 0 0,0%

Target Price a 12 Mesi

6 analisti · 2026-08-14

Mediana $52.00

Ora $46.23

Basso $40.00

Alto $64.00

Target mediano $52.00 +12,5%

Target medio $52.33 +13,2%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media

0.06%

Periodo	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	$0.37	$0.24	0.13%
31 Marzo 2026	$0.34	$0.14	0.20%
31 Dicembre 2025	$0.12	$0.24	-0.12%
30 Settembre 2025	$0.28	$0.14	0.14%
30 Giugno 2025	$0.10	$0.12	-0.02%
31 Marzo 2025	$0.09	$0.07	0.02%

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
CDNA	$959M	-47.1	13.8%	-5.6%	-6.8%	—
SLS	$577M	-15.1	—	—	-55.4%	—
RARE	$2.22B	-3.9	20.2%	-85.4%	-1613.2%	—
BCRX	$1.66B	6.4	94.1%	30.2%	-97.6%	—
COAG	—	—	—	—	—	—
KLRA	—	—	—	—	—	—
PGEN	$1.48B	-3.1	146.7%	-2588.2%	3159.1%	—
VERA	—	-10.9	—	—	-55.9%	—
MLYS	$2.96B	-15.8	—	—	-32.2%	—
VCEL	$1.82B	112.5	16.4%	6.0%	5.0%	74.4%
PVLA	$1.30B	-28.2	65.3%	-1610.6%	-110.1%	—

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 16

Dati annuali Conto Economico per CDNA
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$380M	$334M	$280M	$322M	$296M	$192M	$127M	$77M	$48M	$41M	$28M	$27M
Cost of Revenue	·	·	·	·	·	·	$45M	$33M	$21M	$10M	$0	$0
Gross Profit	·	·	·	·	·	·	$82M	$44M	$27M	·	·	·
R&D Expense	$71M	$73M	$82M	$90M	$77M	$49M	$31M	$15M	$12M	$12M	$9M	$4M
SG&A Expense	$108M	$125M	$119M	$100M	$75M	$49M	$37M	$23M	$20M	$21M	$12M	$8M
Operating Expenses	$411M	$293M	$484M	$399M	$326M	$215M	$152M	$92M	$47M	$78M	$40M	$26M
Operating Income	$-31M	$41M	$-203M	$-77M	$-30M	$-23M	$-25M	$-16M	$-20M	$-37M	$-12M	$1M
Other Non-op	$524.0K	$329.0K	$1M	$-3M	$-3M	$-811.0K	$-719.0K	$-178.0K	$-1M	$-2M	$-188.0K	$-78.0K
Pretax Income	$-21M	$53M	$-190M	$-76M	$-32M	$-20M	$-24M	$-48M	$-57M	$-41M	$-14M	$-719.0K
Income Tax	$271.0K	$310.0K	$141.0K	$379.0K	$-1M	$-1M	$-2M	$-1M	$-2M	$-2M	$0	$-2M
Net Income	$-21M	$53M	$-190M	$-77M	$-31M	$-19M	$-22M	$-47M	$-55M	$-39M	$-14M	$781.0K
EPS (Basic)	$-0.40	$1.00	$-3.54	$-1.44	$-0.59	$-0.40	$-0.52	$-1.31	$-2.38	$-2.39	$-1.16	$0.13
EPS (Diluted)	$-0.40	$0.93	$-3.54	$-1.44	$-0.59	$-0.40	$-0.52	$-1.31	$-2.38	$-2.39	$-1.16	$0.10
Shares (Basic)	53,287,546	52,773,247	53,764,705	53,321,625	52,241,076	46,481,772	42,151,617	35,638,956	23,332,503	16,496,911	11,860,885	5,815,928
Shares (Diluted)	53,287,546	56,620,590	53,764,705	53,321,625	52,241,076	46,481,772	42,151,617	35,638,956	23,332,503	16,496,911	11,860,885	9,283,001
EBITDA	$-16M	$55M	$-189M	$-77M	$-30M	$-23M	$-25M	$-16M	$-20M	·	·	$2M

Stato Patrimoniale 28

Dati annuali Stato Patrimoniale per CDNA
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$65M	$115M	$82M	$90M	$348M	$135M	$38M	$65M	$17M	$17M	$30M	$36M
Short-term Investments	$112M	$146M	$153M	$203M	$0	$90M	$0	·	·	·	·	·
Receivables	$43M	$65M	$51M	$66M	$60M	$35M	$24M	$10M	$3M	$3M	·	·
Inventory	$27M	$20M	$19M	$19M	$17M	$10M	$6M	$5M	$6M	$5M	$766.0K	$686.0K
Prepaid Expense	$11M	$7M	$8M	$9M	$8M	$4M	$4M	$2M	$1M	$1M	$1M	$542.0K
Current Assets	$257M	$352M	$314M	$388M	$433M	$273M	$72M	$81M	$27M	$27M	$34M	$40M
PP&E (Net)	$33M	$34M	$35M	$36M	$22M	$11M	$4M	$4M	$2M	$3M	$2M	$2M
PP&E (Gross)	·	·	·	·	·	·	·	$18M	$18M	$17M	$14M	$13M
Accum. Depreciation	·	·	·	·	·	·	·	$14M	$15M	$14M	$12M	$11M
Goodwill	$40M	$40M	$40M	$38M	$37M	$24M	$24M	$12M	$12M	$14M	$12M	$12M
Intangibles	$32M	$38M	$46M	$43M	$50M	$44M	$46M	$33M	$33M	$33M	$7M	$7M
Other Non-current Assets	$3M	$2M	$1M	$4M	$6M	$1M	$1M	$0	$0	$20.0K	$49.0K	$25.0K
Total Assets	$413M	$491M	$467M	$543M	$567M	$369M	$152M	$131M	$84M	$77M	$56M	$61M
Accounts Payable	$10M	$8M	$13M	$10M	$13M	$10M	$6M	$5M	$3M	$3M	$2M	$1M
Current Liabilities	$90M	$89M	$78M	$76M	$77M	$69M	$35M	$20M	$43M	$41M	$10M	$11M
Capital Leases	$20M	$22M	$28M	$33M	$17M	$16M	$2M	$249.0K	$14.0K	$26.0K	$57.0K	$106.0K
Deferred Tax	$181.0K	$164.0K	$136.0K	$0	$415.0K	$1M	$2M	$3M	$5M	$6M	$0	·
Other Non-current Liabilities	$418.0K	$645.0K	$97M	$249.0K	$455.0K	$240.0K	$2M	$2M	$1M	$1M	$28.0K	$28.0K
Total Liabilities	$110M	$113M	$205M	$112M	$101M	$91M	$53M	$35M	$90M	$57M	$26M	$20M
Long-term Debt	·	·	·	·	·	$0	$0	$0	$34M	$24M	$16M	$11M
Total Debt	·	·	·	·	·	$0	$0	$0	$34M	·	·	$11M
Common Stock	$50.0K	$51.0K	$49.0K	$52.0K	$52.0K	$49.0K	$42.0K	$41.0K	$29.0K	$21.0K	$12.0K	$12.0K
Paid-in Capital	·	·	·	·	·	·	·	·	·	$236M	$203M	$201M
Retained Earnings	$-619M	$-626M	$-678M	$-460M	$-383M	$-353M	$-334M	$-312M	$-268M	$-213M	$-173M	$-159M
AOCI	$-6M	$-9M	$-7M	$-8M	$-5M	$-2M	$-5M	$-4M	$-2M	$-4M	$0	·
Stockholders' Equity	$303M	$378M	$261M	$431M	$466M	$278M	$99M	$96M	$-6M	$19M	$29M	$41M
Liabilities + Equity	$413M	$491M	$467M	$543M	$567M	$369M	$152M	$131M	$84M	$77M	$56M	$61M
Shares Outstanding	50,916,644	54,771,203	51,503,377	53,533,250	52,923,360	49,441,166	42,498,430	41,384,960	28,825,019	21,278,373	11,902,363	11,803,970

Flusso di cassa 16

Dati annuali Flusso di cassa per CDNA
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$15M	$14M	$14M	$12M	$9M	$7M	$6M	$4M	$4M	$3M	$796.0K	$512.0K
Stock-based Comp	$35M	$66M	$49M	$47M	$36M	$23M	$22M	$7M	$2M	$2M	$1M	$535.0K
Deferred Tax	$-149.0K	$101.0K	$72.0K	$-278.0K	$-1M	$-1M	$-1M	$-2M	$-2M	$-2M	$0	$-2M
Amort. of Intangibles	$6M	$6M	$6M	$6M	$6M	$5M	$4M	$2M	$3M	$2M	$0	·
Restructuring	·	$2M	$2M	$0	$0	·	·	·	·	·	·	·
Other Non-cash	$14M	$-95M	$108M	·	·	·	·	·	·	·	·	$-5M
Operating Cash Flow	$42M	$38M	$-18M	$-25M	$-19M	$33M	$-3M	$-4M	$-14M	$-17M	$-10M	$-3M
CapEx	·	·	·	·	·	·	·	$2M	$186.0K	$549.0K	$1M	$733.0K
Investing Cash Flow	$2M	$-483.0K	$40M	$-229M	$48M	$-100M	$-23M	$-8M	$-6M	$-21M	·	·
Stock Issued	·	·	$0	$0	$189M	·	·	·	·	·	·	·
Stock Repurchased	$88M	$522.0K	$28M	$642.0K	$0	$0	·	·	·	·	·	·
Net Stock Activity	$-88M	$-522.0K	$-28M	$-642.0K	·	·	·	·	·	·	·	·
Financing Cash Flow	$-93M	$-6M	$-30M	$-5M	$186M	$163M	$-132.0K	$50M	$29M	$25M	·	·
Net Change in Cash	$-49M	$32M	$-8M	$-258M	$214M	$96M	$-26M	$38M	$9M	$-13M	$-7M	$31M
Taxes Paid	$284.0K	$317.0K	$738.0K	$392.0K	$14.0K	$80.0K	$0	$0	·	·	·	·
Free Cash Flow	·	·	·	·	·	·	·	$-6M	$-14M	·	·	$-4M

Redditività 8

Dati annuali Redditività per CDNA
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Gross Margin	·	·	·	·	·	·	64.2%	·	·	·	·	·
Operating Margin	-8.1%	12.2%	-72.5%	-24.0%	-10.0%	-11.7%	-19.3%	-20.3%	-42.0%	·	·	4.6%
Net Margin	-5.6%	15.7%	-67.9%	-23.8%	-10.3%	-9.7%	-17.3%	-61.1%	-114.8%	·	·	2.9%
Pretax Margin	-5.5%	15.8%	-67.8%	-23.7%	-10.8%	-10.3%	-18.9%	-63.0%	-118.5%	·	·	-2.6%
EBITDA Margin	-4.2%	16.5%	-67.4%	-24.0%	-10.0%	-11.7%	-19.3%	-20.3%	-42.0%	·	·	6.5%
ROA	-4.7%	11.0%	-37.7%	-13.8%	-6.6%	-7.2%	-15.6%	-43.6%	-69.9%	·	·	2.2%
ROE	-6.8%	16.1%	-58.1%	-17.1%	-6.5%	-6.9%	-22.4%	-104.1%	-831.1%	·	·	-1.4%
ROIC	-10.3%	10.7%	-77.9%	-18.0%	-6.1%	-7.7%	-22.7%	-15.8%	-70.5%	·	·	-2.6%

Liquidità e Solvibilità 4

Dati annuali Liquidità e Solvibilità per CDNA
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	2.9	3.9	4.0	5.1	5.6	3.9	2.1	4.2	0.6	·	·	3.6
Quick Ratio	2.4	3.6	3.7	4.7	5.3	3.7	1.8	3.8	0.5	·	·	3.3
Debt / Equity	·	·	·	·	·	0.0	0.0	0.0	-5.6	·	·	0.3
LT Debt / Equity	·	·	·	·	·	0.0	0.0	0.0	-3.0	·	·	0.1

Efficienza 3

Dati annuali Efficienza per CDNA
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.8	0.7	0.6	0.6	0.6	0.7	0.9	0.7	0.6	·	·	0.8
Inventory Turnover	·	·	·	·	·	·	8.3	·	1.6	·	·	14.2
Receivables Turnover	7.1	5.8	4.8	5.1	6.3	6.6	7.5	12.0	16.8	·	·	·

Per Azione 5

Dati annuali Per Azione per CDNA
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$5.95	$6.91	$5.07	$8.05	$8.80	$5.62	$2.33	$2.32	$-0.21	·	·	$3.50
Revenue / Share	$7.13	$5.90	$5.21	$6.03	$5.67	$4.13	$3.01	$2.15	$2.07	·	·	$2.94
Cash Flow / Share	$0.79	$0.67	$-0.34	$-0.47	$-0.37	$0.72	$-0.07	$-0.11	$-0.61	·	·	$-0.36
Cash / Share	$1.28	$2.09	$1.60	$1.68	$6.58	$2.72	$0.90	$1.56	$0.59	·	·	$3.09
EPS (TTM)	$-0.40	$0.93	$-3.54	$-1.44	$-0.59	$-0.40	$-0.52	$-1.31	$-2.38	$-2.39	$-1.16	$0.10

Tassi di Crescita 3

Dati annuali Tassi di Crescita per CDNA
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	13.8%	19.1%	-12.9%	8.6%	54.2%	·	·	·	·	·	·	·
Revenue CAGR 3Y	5.7%	4.0%	13.4%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	14.6%	·	·	·	·	·	·	·	·	·	·	·

Valutazione (TTM) 14

Dati annuali Valutazione (TTM) per CDNA
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$380M	$334M	$280M	$322M	$296M	$192M	$127M	$77M	$48M	$41M	$28M	$27M
Net Income TTM	$-21M	$53M	$-190M	$-77M	$-31M	$-19M	$-22M	$-47M	$-55M	$-39M	$-14M	$781.0K
Market Cap	$959M	$1.17B	$618M	$611M	$2.41B	$3.58B	$917M	$1.04B	$212M	·	·	$86M
Enterprise Value	·	·	·	·	·	$3.36B	$878M	$976M	$229M	·	·	$61M
P/E	-47.1	23.0	-3.4	-7.9	-77.1	-181.1	-41.5	-19.2	-3.1	-1.1	-5.5	72.5
P/S	2.5	3.5	2.2	1.9	8.1	18.6	7.2	13.6	4.4	·	·	3.1
P/B	3.2	3.1	2.4	1.4	5.2	12.9	9.3	10.8	-34.5	·	·	2.1
P / Tangible Book	4.2	3.9	3.5	1.7	6.4	17.1	·	·	·	·	·	·
P / Cash Flow	22.8	30.8	-33.6	-24.2	-124.8	107.1	-331.1	-259.7	-14.8	·	·	-25.5
P / FCF	·	·	·	·	·	·	·	-172.2	-14.6	·	·	-21.0
EV / EBITDA	·	·	·	·	·	-149.0	-35.8	-62.6	-11.3	·	·	34.4
EV / FCF	·	·	·	·	·	·	·	-161.5	-15.8	·	·	-14.8
EV / Revenue	·	·	·	·	·	17.5	6.9	12.7	4.7	·	·	2.2
Earnings Yield	-2.1%	4.3%	-29.5%	-12.6%	-1.3%	-0.55%	-2.4%	-5.2%	-32.4%	-88.5%	-18.1%	1.4%

Conto Economico 14

Dati trimestrali Conto Economico per CDNA
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$132M	$118M	$108M	$100M	$87M	$85M	$87M	$83M	$92M	$72M	$66M	$67M	$70M	$77M	$82M	$79M
R&D Expense	$22M	$21M	$19M	$17M	$17M	$19M	$17M	$17M	$20M	$19M	$19M	$19M	$20M	$24M	$24M	$22M
SG&A Expense	$41M	$30M	$29M	$28M	$28M	$23M	$32M	$32M	$31M	$30M	$28M	$34M	$29M	$28M	$25M	$24M
Operating Expenses	$19M	$117M	$114M	$100M	$98M	$98M	$2M	$97M	$100M	$95M	$188M	$96M	$98M	$102M	$102M	$97M
Operating Income	$113M	$1M	$-6M	$-246.0K	$-11M	$-13M	$84M	$-14M	$-7M	$-23M	$-123M	$-29M	$-28M	$-24M	$-19M	$-17M
Other Non-op	$-440.0K	$-330.0K	$264.0K	$-107.0K	$72.0K	$295.0K	$436.0K	$283.0K	$-100.0K	$-290.0K	$2M	$2M	$-271.0K	$-2M	$-924.0K	$-572.0K
Pretax Income	$115M	$3M	$-4M	$2M	$-9M	$-10M	$88M	$-10M	$-5M	$-20M	$-118M	$-24M	$-25M	$-24M	$-18M	$-17M
Income Tax	$4M	$-32.0K	$345.0K	$-15.0K	$-117.0K	$58.0K	$171.0K	$200.0K	$22.0K	$-83.0K	$165.0K	$-80.0K	$-68.0K	$124.0K	$173.0K	$267.0K
Net Income	$111M	$3M	$-4M	$2M	$-9M	$-10M	$88M	$-11M	$-5M	$-20M	$-118M	$-23M	$-25M	$-24M	$-18M	$-17M
EPS (Basic)	$2.15	$0.05	$-0.08	$0.03	$-0.16	$-0.19	$1.67	$-0.20	$-0.09	$-0.38	$-2.21	$-0.43	$-0.46	$-0.44	$-0.34	$-0.32
EPS (Diluted)	$2.07	$0.05	$-0.08	$0.03	$-0.16	$-0.19	$1.60	$-0.20	$-0.09	$-0.38	$-2.21	$-0.43	$-0.46	$-0.44	$-0.34	$-0.32
Shares (Basic)	51,469,375	51,151,794	-108,787,249	52,507,582	54,304,754	55,262,459	-104,018,069	52,903,338	52,195,620	51,692,358	-107,903,530	54,178,759	53,846,260	53,643,216	-106,432,797	53,489,418
Shares (Diluted)	53,422,523	53,129,928	-110,016,457	53,736,790	54,304,754	55,262,459	-100,170,726	52,903,338	52,195,620	51,692,358	-107,903,530	54,178,759	53,846,260	53,643,216	-106,432,797	53,489,418
EBITDA	$113M	$5M	·	$-246.0K	$-11M	$-10M	·	$-10M	$-4M	$-16M	·	$-29M	$-28M	$-21M	·	$-17M

Stato Patrimoniale 24

Dati trimestrali Stato Patrimoniale per CDNA
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$374M	$78M	$65M	$91M	$68M	$89M	$115M	$95M	$96M	$93M	$82M	$76M	$88M	$75M	$90M	$83M
Short-term Investments	$0	$109M	$112M	$103M	$118M	$142M	$146M	$145M	$133M	$123M	·	$192M	$195M	$211M	·	$208M
Receivables	$34M	$45M	$43M	$48M	$67M	$71M	$65M	$67M	$66M	$60M	·	$52M	$52M	$59M	·	$70M
Inventory	$7M	$26M	$27M	$28M	$28M	$23M	$20M	$19M	$19M	$20M	·	$18M	$19M	$18M	·	$18M
Prepaid Expense	$14M	$11M	$11M	$30M	$26M	$25M	$7M	$7M	$6M	$7M	·	$7M	$8M	$8M	·	$8M
Current Assets	$429M	$269M	$257M	$300M	$307M	$350M	$352M	$334M	$321M	$303M	·	$345M	$361M	$371M	·	$388M
PP&E (Net)	$27M	$33M	$33M	$31M	$32M	$33M	$34M	$34M	$34M	$34M	·	$35M	$36M	$36M	·	$34M
Goodwill	$36M	$40M	$40M	$40M	$40M	$40M	$40M	$40M	$40M	$40M	·	$40M	$40M	$40M	$38M	$38M
Intangibles	$19M	$32M	$32M	$33M	$36M	$37M	$38M	$40M	$42M	$43M	·	$46M	$44M	$46M	·	$44M
Other Non-current Assets	$6M	$3M	$3M	$3M	$3M	$2M	$2M	$2M	$2M	$2M	·	$2M	$2M	$2M	·	$5M
Total Assets	$533M	$411M	$413M	$432M	$444M	$490M	$491M	$477M	$467M	$452M	·	$501M	$515M	$528M	·	$545M
Accounts Payable	$9M	$9M	$10M	$12M	$10M	$8M	$8M	$6M	$6M	$10M	·	$9M	$10M	$13M	·	$11M
Current Liabilities	$94M	$79M	$90M	$99M	$93M	$85M	$89M	$81M	$78M	$70M	·	$73M	$74M	$72M	·	$70M
Capital Leases	$13M	$18M	$20M	$21M	$23M	$24M	$22M	$24M	$25M	$27M	·	$29M	$31M	$32M	·	$35M
Deferred Tax	$86.0K	$130.0K	$181.0K	$117.0K	$131.0K	$129.0K	$164.0K	$202.0K	$50.0K	$43.0K	·	$140.0K	$51.0K	·	·	$13.0K
Other Non-current Liabilities	$406.0K	$407.0K	$257.0K	$634.0K	$636.0K	$644.0K	$645.0K	$97M	$97M	$98M	·	$245.0K	$247.0K	$248.0K	·	$251.0K
Total Liabilities	$107M	$98M	$110M	$121M	$117M	$110M	$113M	$204M	$202M	$196M	·	$107M	$110M	$108M	·	$108M
Long-term Debt	·	·	·	·	·	·	·	$0	$0	·	·	·	·	·	·	·
Common Stock	$51.0K	$51.0K	$50.0K	$51.0K	$53.0K	$51.0K	$51.0K	$50.0K	$50.0K	$49.0K	·	$52.0K	$52.0K	$52.0K	·	$52.0K
Retained Earnings	$-505M	$-733M	$-735M	$-719M	$-695M	$-637M	$-626M	$-704M	$-697M	$-695M	·	$-534M	$-510M	$-485M	·	$-441M
AOCI	$0	$-6M	$-6M	$-6M	$-6M	$-7M	$-9M	$-7M	$-8M	$-8M	·	$-9M	$-8M	$-7M	·	$-9M
Stockholders' Equity	$426M	$314M	$303M	$311M	$327M	$379M	$378M	$273M	$265M	$256M	$261M	$394M	$405M	$420M	$431M	$437M
Liabilities + Equity	$533M	$411M	$413M	$432M	$444M	$490M	$491M	$477M	$467M	$452M	·	$501M	$515M	$528M	·	$545M
Shares Outstanding	51,482,536	51,274,651	50,916,644	51,407,335	53,220,123	55,462,730	54,771,203	53,106,871	52,617,443	51,782,612	51,503,377	54,153,496	54,013,601	53,653,182	53,533,250	53,523,453

Flusso di cassa 14

Dati trimestrali Flusso di cassa per CDNA
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$3M	$4M	$4M	$4M	$4M	$4M	$3M	$3M	$4M	$4M	$4M	$4M	$4M	$3M	$3M	$3M
Stock-based Comp	$11M	$10M	$8M	$8M	$9M	$9M	$17M	$23M	$20M	$17M	$10M	$13M	$13M	$14M	$12M	$11M
Amort. of Intangibles	$529.0K	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Restructuring	·	·	·	·	·	·	·	$0	$68.0K	·	·	$0	$848.0K	$60.0K	$0	$0
Other Non-cash	·	$-12M	·	·	·	$-29M	·	·	·	$-16M	·	·	·	$7M	·	·
Operating Cash Flow	$31M	$4M	$21M	$37M	$10M	$-27M	$22M	$13M	$19M	$-15M	$-8M	$-10M	$-499.0K	$671.0K	$7M	$-7M
CapEx	$2M	$4M	·	·	$1M	$2M	·	·	·	·	·	·	·	·	·	·
Investing Cash Flow	$281M	$11M	$-35M	$12M	$23M	$1M	$-2M	$-14M	$-12M	$28M	$41M	$-1M	$15M	$-15M	$2M	$-76M
Stock Issued	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$0
Stock Repurchased	·	·	$12M	$26M	$50M	$0	$0	$0	$0	$522.0K	$26M	$814.0K	$67.0K	$690.0K	$642.0K	$0
Net Stock Activity	·	·	·	·	·	$0	·	·	·	$-522.0K	·	·	·	$-690.0K	·	·
Financing Cash Flow	$-15M	$-3M	$-12M	$-26M	$-54M	$-643.0K	$-903.0K	$1M	$-5M	$-1M	$-27M	$-25.0K	$-2M	$-1M	$-2M	$-1M
Net Change in Cash	$296M	$12M	$-26M	$23M	$-21M	$-26M	$19M	$-378.0K	$2M	$11M	$6M	$-12M	$13M	$-15M	$7M	$-84M
Free Cash Flow	·	$514.0K	·	·	·	·	·	·	·	·	·	·	·	·	·	·

Redditività 7

Dati trimestrali Redditività per CDNA
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	85.8%	1.0%	·	-0.25%	-12.8%	-15.8%	·	-12.7%	-4.4%	-26.8%	·	-42.8%	-39.3%	-31.5%	·	-21.9%
Net Margin	83.9%	2.4%	·	1.7%	-9.9%	-12.2%	·	-8.9%	-1.5%	-23.1%	·	-34.9%	-35.5%	-30.7%	·	-21.3%
Pretax Margin	86.8%	2.4%	·	1.7%	-10.0%	-12.2%	·	-8.7%	-1.5%	-23.2%	·	-35.1%	-35.6%	-30.6%	·	-21.0%
EBITDA Margin	85.8%	4.3%	·	-0.25%	-12.8%	-11.5%	·	-12.7%	-4.4%	-21.5%	·	-42.8%	-39.3%	-27.1%	·	-21.9%
ROA	22.6%	0.62%	·	0.37%	-1.9%	-2.2%	·	-1.5%	-0.28%	-3.4%	·	-4.5%	-4.7%	-4.4%	·	-3.1%
ROE	29.4%	0.81%	·	0.57%	-2.9%	-3.3%	·	-2.2%	-0.42%	-4.9%	·	-5.7%	-5.9%	-5.4%	·	-3.7%
ROIC	25.7%	0.39%	·	-0.08%	-3.4%	-3.5%	·	-4.0%	-1.6%	-7.5%	·	-7.3%	-6.8%	-5.8%	·	-4.0%

Liquidità e Solvibilità 2

Dati trimestrali Liquidità e Solvibilità per CDNA
Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		4.6	3.4	·	3.0	3.3	4.1	·	4.1	4.1	4.3	·	4.7	4.8	5.2	·	5.5
Quick Ratio		4.4	2.9	·	2.4	2.7	3.5	·	3.8	3.8	3.9	·	4.4	4.5	4.8	·	5.1

Efficienza 2

Dati trimestrali Efficienza per CDNA
Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.3	0.3	·	0.2	0.2	0.2	·	0.2	0.2	0.1	·	0.1	0.1	0.1	·	0.1
Receivables Turnover		2.6	2.0	·	1.7	1.3	1.3	·	1.4	1.6	1.2	·	1.1	1.2	1.2	·	1.3

Per Azione 5

Dati trimestrali Per Azione per CDNA
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$8.27	$6.11	·	$6.05	$6.15	$6.84	·	$5.15	$5.03	$4.95	·	$7.28	$7.50	$7.83	·	$8.16
Revenue / Share	$2.47	$2.22	·	$1.86	$1.60	$1.53	·	$1.57	$1.77	$1.39	·	$1.24	$1.31	$1.44	·	$1.48
Cash Flow / Share	·	$0.08	·	·	·	$-0.48	·	·	·	$-0.30	·	·	·	$0.01	·	·
Cash / Share	$7.26	$1.52	·	$1.78	$1.28	$1.60	·	$1.80	$1.82	$1.80	·	$1.40	$1.63	$1.39	·	$1.55
EPS (TTM)	$1.99	$-0.27	·	$-0.52	$-0.64	$-0.86	·	$-1.10	$-1.36	$-1.71	·	$-1.65	$-1.63	$-1.54	·	$-1.33

Valutazione (TTM) 10

Dati trimestrali Valutazione (TTM) per CDNA
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$436M	$389M	·	$354M	$347M	$332M	·	$314M	$302M	$287M	·	$294M	$308M	$317M	·	$315M
Net Income TTM	$107M	$-14M	·	$-28M	$-34M	$-46M	·	$-59M	$-73M	$-92M	·	$-89M	$-87M	$-82M	·	$-70M
Market Cap	$1.47B	$890M	·	$747M	$1.04B	$984M	·	$1.66B	$817M	$548M	·	$379M	$459M	$490M	·	$911M
P/E	14.3	-64.3	·	-28.0	-30.5	-20.6	·	-28.4	-11.4	-6.2	·	-4.2	-5.2	-5.9	·	-12.8
P/S	3.4	2.3	·	2.1	3.0	3.0	·	5.3	2.7	1.9	·	1.3	1.5	1.5	·	2.9
P/B	3.4	2.8	·	2.4	3.2	2.6	·	6.1	3.1	2.1	·	1.0	1.1	1.2	·	2.1
P / Tangible Book	4.0	3.7	·	3.1	4.1	3.3	·	8.6	4.5	3.2	·	1.2	1.4	1.5	·	2.6
P / Cash Flow	·	205.4	·	·	·	-37.0	·	·	·	-35.8	·	·	·	730.8	·	·
P / FCF	·	1731.8	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Earnings Yield	7.0%	-1.6%	·	-3.6%	-3.3%	-4.9%	·	-3.5%	-8.8%	-16.2%	·	-23.6%	-19.2%	-16.9%	·	-7.8%

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$380M	$334M	$280M	$322M	$296M
Margine Operativo %	-8.1%	12.2%	-72.5%	-24.0%	-10.0%
Utile netto	$-21M	$53M	$-190M	$-77M	$-31M
EPS Diluito	$-0.40	$0.93	$-3.54	$-1.44	$-0.59

Stato Patrimoniale

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	2.9	3.9	4.0	5.1	5.6
Quick Ratio	2.4	3.6	3.7	4.7	5.3

Ultime notizie Notizie recenti che menzionano questa società

Il titolo di un operatore di casinò online balza in avanti grazie a un accordo con Crypto.com Prediction Market Yahoo Finance · 4 mesi fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 245 filer · $1.2B totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
61 (+39 vs trimestre precedente)	13 (-16 vs trimestre precedente)	70 (+5 vs trimestre precedente)	65 (+4 vs trimestre precedente)	+1.5M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
STATE STREET CORP	$70.362.453	2.468.858	6,00%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$62.628.038	2.197.475	5,34%	Azioni
DEERFIELD MANAGEMENT COMPANY, L.P.	$56.932.113	1.997.618	4,86%	Azioni
ARK Investment Management LLC	$55.675.622	1.953.531	4,75%	Azioni
BAMCO INC /NY/	$55.213.791	1.937.326	4,71%	Azioni
GAGNON SECURITIES LLC	$50.465.960	1.770.735	4,31%	Azioni
Chevy Chase Trust Holdings, LLC	$40.966.358	1.437.416	3,49%	Azioni
Ophir Asset Management Pty Ltd	$36.047.057	1.264.809	3,08%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$35.424.332	1.242.959	3,02%	Azioni
BRAIDWELL LP	$34.787.157	1.220.602	2,97%	Azioni
Sumitomo Mitsui Trust Group, Inc.	$33.961.455	1.191.630	2,90%	Azioni
Blue Water Life Science Advisors, LP	$33.915.000	1.190.000	2,89%	Azioni
Amova Asset Management Americas, Inc.	$33.848.257	1.188.075	2,89%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$32.444.760	1.138.166	2,77%	Azioni
DIMENSIONAL FUND ADVISORS LP	$31.374.653	1.100.865	2,68%	Azioni
D. E. Shaw & Co., Inc.	$30.249.188	1.061.375	2,58%	Azioni
JACOBS LEVY EQUITY MANAGEMENT, INC	$28.376.566	995.669	2,42%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$28.201.577	989.529	2,41%	Azioni
Divisadero Street Capital Management, LP	$19.976.733	700.938	1,70%	Azioni
Portolan Capital Management, LLC	$19.516.943	684.805	1,67%	Azioni
ROYCE & ASSOCIATES LP	$16.415.174	575.971	1,40%	Azioni
Gagnon Advisors, LLC	$15.586.451	546.893	1,33%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$15.336.563	538.125	1,31%	Azioni
Palo Alto Investors LP	$15.158.295	531.870	1,29%	Azioni
Meridiem Capital Partners LP	$12.867.551	451.493	1,10%	Azioni
GOLDMAN SACHS GROUP INC	$11.848.505	415.737	1,01%	Azioni
TWO SIGMA INVESTMENTS, LP	$11.456.630	401.987	0,98%	Azioni
Zweig-DiMenna Associates LLC	$11.081.142	388.812	0,95%	Azioni
BNP PARIBAS FINANCIAL MARKETS	$10.684.906	374.909	0,91%	Azioni
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$10.605.164	372.111	0,90%	Azioni
Qube Research & Technologies Ltd	$10.540.355	369.837	0,90%	Azioni
VANGUARD FIDUCIARY TRUST CO	$10.446.419	366.541	0,89%	Azioni
JANE STREET GROUP, LLC	$9.862.311	346.046	0,84%	Azioni
ArrowMark Colorado Holdings LLC	$9.648.647	338.549	0,82%	Azioni
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE	$8.680.000	500.000	0,74%	Azioni
SILVERCREST ASSET MANAGEMENT GROUP LLC	$8.441.700	296.200	0,72%	Azioni
Kent Lake PR LLC	$7.997.000	550.000	0,68%	Azioni
Connor, Clark & Lunn Investment Management Ltd.	$7.643.900	268.207	0,65%	Azioni
BANK OF AMERICA CORP /DE/	$7.435.194	260.884	0,63%	Azioni
FMR LLC	$7.191.120	252.320	0,61%	Azioni
AQR CAPITAL MANAGEMENT LLC	$6.872.604	241.144	0,59%	Azioni
Aberdeen Group plc	$6.407.627	224.829	0,55%	Azioni
ExodusPoint Capital Management, LP	$6.108.747	214.342	0,52%	Azioni
Parkman Healthcare Partners LLC	$5.768.885	202.417	0,49%	Azioni
HSBC HOLDINGS PLC	$5.558.029	195.087	0,47%	Azioni
FRED ALGER MANAGEMENT, LLC	$4.849.161	170.146	0,41%	Azioni
Uniplan Investment Counsel, Inc.	$4.478.256	157.131	0,38%	Azioni
Russell Investments Group, Ltd.	$4.314.900	151.400	0,37%	Azioni
Squarepoint Ops LLC	$4.036.256	141.623	0,34%	Azioni
AMERICAN CENTURY COMPANIES INC	$3.676.272	128.992	0,31%	Azioni
Man Group plc	$3.618.417	126.962	0,31%	Azioni
GLOBEFLEX CAPITAL L P	$3.398.682	119.252	0,29%	Azioni
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	$3.327.831	116.766	0,28%	Azioni
STATE OF WISCONSIN INVESTMENT BOARD	$2.872.772	100.799	0,25%	Azioni
IQ EQ FUND MANAGEMENT (IRELAND) Ltd	$2.826.431	99.173	0,24%	Azioni
LAZARD ASSET MANAGEMENT LLC	$2.700.290	94.747	0,23%	Azioni
Kera Capital Partners, Inc.	$2.596.578	91.108	0,22%	Azioni
Swiss National Bank	$2.490.900	87.400	0,21%	Azioni
PRUDENTIAL FINANCIAL INC	$2.432.760	85.360	0,21%	Azioni
Schonfeld Strategic Advisors LLC	$2.379.691	83.498	0,20%	Azioni
Palumbo Wealth Management LLC	$2.363.961	82.946	0,20%	Azioni
Jump Financial, LLC	$2.359.002	82.772	0,20%	Azioni
Regal Partners Ltd	$2.256.773	79.185	0,19%	Azioni
FORMULA GROWTH LTD	$2.223.741	78.026	0,19%	Azioni
Bank of New York Mellon Corp	$2.190.083	76.845	0,19%	Azioni
ARS Investment Partners, LLC	$2.115.698	74.235	0,18%	Azioni
MILLENNIUM MANAGEMENT LLC	$2.103.556	73.809	0,18%	Azioni
Gotham Asset Management, LLC	$2.097.002	73.579	0,18%	Azioni
CITIGROUP INC	$2.080.985	73.017	0,18%	Azioni
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	$2.080.215	72.990	0,18%	Azioni
PRINCIPAL FINANCIAL GROUP INC	$2.022.503	70.965	0,17%	Azioni
RHUMBLINE ADVISERS	$1.943.865	68.206	0,17%	Azioni
TWO SIGMA ADVISERS, LP	$1.927.332	102.300	0,16%	Azioni
BlackRock, Inc.	$1.735.736	60.903	0,15%	Azioni
Boston Partners	$1.606.600	56.372	0,14%	Azioni
XTX Topco Ltd	$1.531.818	53.748	0,13%	Azioni
CANADA PENSION PLAN INVESTMENT BOARD	$1.504.800	52.800	0,13%	Azioni
AMERIPRISE FINANCIAL INC	$1.490.010	52.281	0,13%	Azioni
Quantinno Capital Management LP	$1.391.370	48.820	0,12%	Azioni
WELLINGTON MANAGEMENT GROUP LLP	$1.375.724	48.271	0,12%	Azioni
WELLS FARGO & COMPANY/MN	$1.333.401	46.786	0,11%	Azioni
Trexquant Investment LP	$1.308.378	45.908	0,11%	Azioni
Quadrature Capital Ltd	$1.299.287	45.589	0,11%	Azioni
Susquehanna Portfolio Strategies, LLC	$1.285.977	45.122	0,11%	Azioni
EXCHANGE TRADED CONCEPTS, LLC	$1.073.909	37.681	0,09%	Azioni
VIRTUS ADVISERS, LLC	$1.072.170	37.620	0,09%	Azioni
ALLIANCEBERNSTEIN L.P.	$1.051.669	60.580	0,09%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$986.129	34.601	0,08%	Azioni
VANGUARD ASSET MANAGEMENT, Ltd	$947.112	33.232	0,08%	Azioni
KLP KAPITALFORVALTNING AS	$920.550	32.300	0,08%	Azioni
Rafferty Asset Management, LLC	$905.759	31.781	0,08%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$897.750	31.500	0,08%	Opzione Call
Engineers Gate Manager LP	$870.675	30.550	0,07%	Azioni
MetLife Investment Management, LLC	$852.578	29.915	0,07%	Azioni
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	$796.876	45.903	0,07%	Azioni
STRS OHIO	$758.100	26.600	0,06%	Azioni
TUDOR INVESTMENT CORP ET AL	$736.497	25.842	0,06%	Azioni
CAXTON ASSOCIATES LP	$719.783	33.619	0,06%	Azioni
Jain Global LLC	$685.368	24.048	0,06%	Azioni
Corient Private Wealth LP	$654.276	22.957	0,06%	Azioni

Insider aziendali 36 insider · 19 dirigenti · 12 direttori

Insider	Ruolo	Ultima attività	Azioni possedute	Vendite 12m	Netto 12m
John Walter Hanna JR	President and CEO	16 Luglio 2026 M	653.448	7	$-6.697.115
Reginald Seeto	President and Chief Executive Officer	02 Ottobre 2023 S	479.164	0	$0
Keith Kennedy	CFO & COO	01 Luglio 2026 F	219.924	0	$0
Abhishek Jain	Chief Financial Officer	27 Maggio 2025 F	327.412	0	$0
Ankur Dhingra	Chief Financial Officer	25 Marzo 2022 F	33.146	0	$0
Michael Brian Bell	Chief Financial Officer	03 Novembre 2020 M	103.343	0	$0
Charles Constanti	Chief Financial Officer	17 Febbraio 2017 A	10.000	0	$0
Ken Ludlum	Chief Financial Officer	22 Gennaio 2016 A	48.000	0	$0
Alexander L Johnson	President of Patient and Testing Services	01 Febbraio 2024 A	345.533	0	$0
Mitchell J Nelles	Chief Operating Officer	02 Luglio 2018 S	85.160	0	$0
Jessica Meng	Chief Commercial Officer	01 Luglio 2026 F	168.287	0	$0
Abraham Ronai	Dirigente	20 Settembre 2023 A	515.986	0	$0
Sasha King	Chief Marketing Officer	09 Agosto 2022 A	78.420	0	$0
James P Yee	Chief Medical Officer	01 Luglio 2019 M	42.045	0	$0
John Joseph Sninsky	Chief Scientific Officer	29 Gennaio 2018 F	22.309	0	$0
Anders Karlsson	Chief Commercial Officer	19 Gennaio 2018 A	9.638	0	$0
Todd Whitson	Chief Commercial Officer	17 Febbraio 2017 A	20.000	0	$0
Joshua Defonzo	Chief Commercial Officer	22 Gennaio 2016 A	11.000	0	$0
Matthew J. Meyer	Chief Business Officer	22 Gennaio 2016 A	23.025	0	$0
Hannah Valantine	Direttore	16 Luglio 2026 M	36.686	3	$-1.319.814
Suresh Gunasekaran	Direttore	12 Giugno 2026 A	37.248	0	$0
Richard Bryan Riggsbee	Direttore	12 Giugno 2026 A	39.312	0	$0
Fred Cohen	Direttore	12 Giugno 2026 A	165.060	0	$0
Peter Maag	Direttore	17 Giugno 2025 S	318.846	0	$0
William A Hagstrom	Direttore	11 Giugno 2025 M	53.979	0	$0
Grace Colon	Direttore	16 Giugno 2023 A	23.708	0	$0
Ralph Snyderman	Direttore	04 Ottobre 2022 A	58.177	0	$0
Amy Abernethy	Direttore	22 Gennaio 2019 M	15.837	0	$0
Douglas S Miller	Direttore	01 Aprile 2017 A	17.695	0	$0
Neil Gagnon	Proprietario del 10%	31 Ottobre 2018 S	867.744	0	$0
Jeffrey Adam Novack	—	05 Agosto 2026 S	106.075	2	$-124.351
George Bickerstaff	—	05 Agosto 2026 S	134.061	1	$-925.600
Michael Goldberg	—	04 Agosto 2026 S	61.738	1	$-2.103.582
Christine Cournoyer	—	04 Agosto 2026 S	42.943	1	$-751.040
Arthur A Torres	—	15 Maggio 2026 S	38.665	2	$-214.650
BYERS BROOK H	—	01 Luglio 2016 A	21.912	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Attivisti e proprietari del 5%+ 2 partecipazioni

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
Merckle International GmbH ×3 depositi	28 Marzo 2018	—	Deposito iniziale	—	SEC
Paragon Associates and Paragon Associates II Joint Venture, Paragon JV Partners, LLC, Bradbury Dyer III ×4 depositi	24 Gennaio 2018	—	Deposito iniziale	—	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Proprietà ETF Posseduti da 52 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
PBE · Invesco Exchange-Traded Fund Trust	5,19%	402.579 SH	08 Agosto 2026	Giornaliero
ARKG · ARK ETF Trust	3,38%	2.009.757 NS	30 Aprile 2026	N-PORT
HTEC · EXCHANGE TRADED CONCEPTS TRUST	1,84%	47.248 NS	30 Aprile 2026	N-PORT
GNOM · Global X Funds	1,05%	25.735 NS	31 Maggio 2026	N-PORT
JSML · Janus Detroit Street Trust	0,55%	82.803 NS	30 Aprile 2026	N-PORT
IWC · iShares Trust	0,52%	174.017 SH	08 Agosto 2026	Giornaliero
JSMD · Janus Detroit Street Trust	0,47%	220.863 NS	30 Aprile 2026	N-PORT
LABU · Direxion Shares ETF Trust	0,34%	84.742 NS	30 Aprile 2026	N-PORT
OMFS · Invesco Exchange-Traded Self-Indexe…	0,31%	19.058 SH	08 Agosto 2026	Giornaliero
GSSC · Goldman Sachs ETF Trust	0,17%	73.893 NS	31 Maggio 2026	N-PORT
IBB · iShares Trust	0,16%	342.939 SH	08 Agosto 2026	Giornaliero
IWO · iShares Trust	0,14%	461.916 SH	08 Agosto 2026	Giornaliero
PRFZ · Invesco Exchange-Traded Fund Trust	0,13%	81.207 SH	08 Agosto 2026	Giornaliero
ESML · iShares Trust	0,11%	69.465 SH	08 Agosto 2026	Giornaliero
VTWG · VANGUARD SCOTTSDALE FUNDS	0,09%	54.986 SH	08 Agosto 2026	Giornaliero
NUSC · Nushares ETF Trust	0,09%	53.421 NS	30 Aprile 2026	N-PORT
PKW · Invesco Exchange-Traded Fund Trust	0,08%	30.942 SH	08 Agosto 2026	Giornaliero
VFMF · VANGUARD WELLINGTON FUND	0,08%	19.899 SH	08 Agosto 2026	Giornaliero
AVSC · AMERICAN CENTURY ETF TRUST	0,08%	92.272 NS	31 Maggio 2026	N-PORT
IWM · iShares Trust	0,07%	1.314.406 SH	08 Agosto 2026	Giornaliero
SMLF · iShares Trust	0,06%	60.421 SH	08 Agosto 2026	Giornaliero
VTWO · VANGUARD SCOTTSDALE FUNDS	0,04%	295.088 SH	08 Agosto 2026	Giornaliero
ISCV · iShares Trust	0,03%	5.217 SH	08 Agosto 2026	Giornaliero
ISCG · iShares Trust	0,03%	7.413 SH	08 Agosto 2026	Giornaliero
ISCB · iShares Trust	0,03%	2.085 SH	08 Agosto 2026	Giornaliero
RSSL · Global X Funds	0,03%	21.791 NS	30 Aprile 2026	N-PORT
VFQY · VANGUARD WELLINGTON FUND	0,03%	4.860 SH	08 Agosto 2026	Giornaliero
ITWO · ProShares Trust	0,03%	2.369 NS	31 Maggio 2026	N-PORT
SCHA · SCHWAB STRATEGIC TRUST	0,03%	249.928 NS	31 Maggio 2026	N-PORT
DFAS · Dimensional ETF Trust	0,02%	168.045 NS	30 Aprile 2026	N-PORT
WSML · iShares Trust	0,02%	3.611 SH	08 Agosto 2026	Giornaliero
VXF · VANGUARD INDEX FUNDS	0,02%	591.907 SH	08 Agosto 2026	Giornaliero
VHT · VANGUARD WORLD FUND	0,02%	131.033 SH	08 Agosto 2026	Giornaliero
FHLC · FIDELITY COVINGTON TRUST	0,02%	24.115 NS	30 Aprile 2026	N-PORT
UWM · ProShares Trust	0,02%	1.853 NS	31 Maggio 2026	N-PORT
DXUV · Dimensional ETF Trust	0,02%	2.943 NS	30 Aprile 2026	N-PORT
DFAT · Dimensional ETF Trust	0,01%	81.837 NS	30 Aprile 2026	N-PORT
URTY · ProShares Trust	0,01%	1.873 NS	31 Maggio 2026	N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS	0,01%	2.162 NS	31 Maggio 2026	N-PORT
DFAC · Dimensional ETF Trust	0,01%	136.968 NS	30 Aprile 2026	N-PORT
HDG · ProShares Trust	0,01%	47 NS	31 Maggio 2026	N-PORT
DFSU · Dimensional ETF Trust	0,00%	3.976 NS	30 Aprile 2026	N-PORT
ITOT · iShares Trust	0,00%	76.922 SH	08 Agosto 2026	Giornaliero
TILT · FlexShares Trust	0,00%	3.021 NS	30 Aprile 2026	N-PORT
IWV · iShares Trust	0,00%	13.093 SH	08 Agosto 2026	Giornaliero
DCOR · Dimensional ETF Trust	0,00%	4.121 NS	30 Aprile 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	11.820 NS	30 Aprile 2026	N-PORT
DFUS · Dimensional ETF Trust	0,00%	20.442 NS	30 Aprile 2026	N-PORT
DFUV · Dimensional ETF Trust	0,00%	12.691 NS	30 Aprile 2026	N-PORT
SCHB · SCHWAB STRATEGIC TRUST	0,00%	30.686 NS	31 Maggio 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	1.554.868 SH	08 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	4.148 SH	08 Agosto 2026	Giornaliero

Informazioni su CareDx, Inc. - Common Stock Panoramica della società da Wikipedia

CDNA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

CDNA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Medie mobili e sovrapposizioni

Volume

Oscillatori

Momentum e tendenza

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

CDNA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Ultime notizie Notizie recenti che menzionano questa società

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

Proprietari istituzionali (13F) 245 filer · $1.2B totale · Aggiornato al 30 Giugno 2026

Insider aziendali 36 insider · 19 dirigenti · 12 direttori

Attivisti e proprietari del 5%+ 2 partecipazioni

Proprietà ETF Posseduti da 52 ETF